30 Day Trial

Seikagaku up 5.9% in 2Q19 on US Reimbursement

Seikagaku reports FY 1Q19 revenue of ¥7,649MM (USD $69.1MM), +5.9% vs. FY 1Q18.

Orthofix Up +3.9% in 2Q19 on Biologics Outperformance

Orthofix reports 2Q19 revenue of USD $115.9MM, +3.9% vs. 2Q18.

Collagen Matrix Acquired by Private Equity Firm

Collagen Matrix, manufacturer of collagen- and mineral-based products for tissue and bone repair and regeneration, was acquired by Linden Capital Partners.

Globus Up +12.2% in 2Q19 on Spine Implant Sales

Globus Medical posts 2Q19 revenue of USD $194.5MM, +12.2% vs. 2Q18.

Alphatec Launches InVictus MIS SingleStep K-wireless Delivery System

Alphatec launched the InVictus™ MIS SingleStep K-wireless implant delivery system to limit potential complications from inadvertent K-wire advancement during pedicle screw placement.

Camber Spine Enters Cellular Bone Graft Market

Camber Spine is offering SCYLLA™, an allogeneic bone matrix product containing viable spine-derived cells that is complementary to its SPIRA® and ENZA® spinal fusion devices.

NanoFUSE Launches Biologic Product in Panama

NanoFUSE Biologics is introducing its bioactive glass + DBM biologic in Panama.

RTI Up +18.7% in 2Q19 on Paradigm Spine Acquisition

RTI Surgical posts 2Q19 orthopedic revenue of USD $71.6MM, +18.7% vs 2Q18.

Conformis Up 2.3% in 2Q19 Amid Coverage Issues

Conformis posts 2Q19 revenue of USD $19.3MM, +2.3% vs 2Q18.

Orthofix Names Jon Serbousek as Successor to Retiring President & CEO

Orthofix Medical named Jon Serbousek as President of its Global Spine business effective August 5, 2019, and successor to the retiring President and CEO, to be effective in 4Q19.


It's important to know that ORTHOFLASH (like many ORTHOWORLD resources) is included with Membership. The full menu of Membership benefits is outlined on this pageStill have questions? Or, would you prefer personal attention?
Fran Bursic welcomes your inquiry by phone at 440.543.2101 or via 

Read more from ORTHOWORLD: